Innovative Interventions for Smoking Cessation

Completed · Phase 2

Conditions studied: Tobacco Use Disorder

In brief

The purpose of this study is to evaluate the effect of a combination of the 21 mg nicotine patch and very low nicotine content (VLNC) cigarettes compared to 21 mg nicotine patch only and very low nicotine content cigarette only on abstinence, time to relapse and toxicant levels. The study will determine if adding nicotine replacement medication to the very low content cigarettes (VLNC) will augment treatment compared to nicotine patch only or to very low nicotine content cigarettes only.

Key facts

Study ID

NCT01050569

Run by

University of Minnesota

People needed

235

Starts

2008-10-01

Expected to finish

2012-06-01

Last updated by the study team

2019-11-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• a) Smoking at least 10 cigarettes daily for the past year;
• b) In good physical health;
• c) No contraindications for medicinal nicotine; and
• d) Stable, good mental health.

You may not qualify if…

• a) Subjects must not be using other tobacco or nicotine products.
• b) Female subjects cannot be pregnant or nursing and must be using appropriate birth control.

Where it is running

• University of Minnesota — Duluth, Minnesota, United States
• University of MN's Tobacco Use Research Center — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.